* * * TABLE OF CONTENTS * * * 
I. Call to Order 7 
II. Minutes of the March 1-2, 1993, Meeting 7 
III. Data Management Report-Review of Semiannual Report Forms for NIH- 
Approved Human Gene Transfer Protocols/Dr. Leventhal 7 
IV. Minor Modifications to NIH-Approved Human Gene Transfer Protocols 8 
V. Addition to Appendix D of the NIH Guidelines Regarding a Human Gene 
Therapy Protocol Entitled: A Phase I Trial of Human Gamma Interferon 
-Transduced Autologous Tumor Cells in Patients with Disseminated 
Malignant Melanoma /Dr. Seigler 9 
VI. Addition to Appendix D of the NIH Guidelines Regarding a Human Gene 
Therapy Protocol Entitled: Use of Modified Retroviruses to Introduce 
Chemotherapy Resistance Sequences into Normal Hematopoietic Cells for 
Chemoprotection During the Therapy of Ovarian Cancer: A Pilot 
Trial /Drs. Deisseroth, Kavanagh, Champlin 10 
VII. Amendment to the Human Gene Therapy Protocol Entitled: Treatment 
of Severe Combined Immune Deficiency (SCID) Due to Adenosine Deaminase 
(ADA) Deficiency with CD34(+) Selected Autologous Hematopoietic Stem 
Cells/Dr. Blaese 13 
VIII. Addition to Appendix D of the NIH Guidelines Regarding a Human 
Gene Therapy Protocol Entitled: Immunotherapy for Cancer by Direct 
Gene Transfer into Tumors /Dr. Nabel 16 
IX. Working Group Report on the Submission of Human Gene Transfer 
Protocols/Dr. Brinckerhoff 19 
X. Addition to Appendix D of the NIH Guidelines Regarding a Human Gene 
Therapy Protocol Entitled: Gene Therapy for Gaucher Disease: Ex 
Vivo Gene Transfer and Autologous Transplantation of CD34( + ) 
Cells/Dr. Barranger 20 
[540] 
Recombinant DNA Research, Volume 17 
